A new technique based on machine learning and stem cells may lead to personalized testing for hazardous chemicals and make toxin testing on animals a thing of the past. Dubbed ‘forever chemicals’ ...

Early in the pandemic, when someone walked into a clinic with a possible case of COVID-19, a nurse or doctor would stick a long swab up their nose to take a sample. They would then ship it to a ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Students have found a new way to cheat on tests and teachers are finding it very difficult to spot. Smart glasses are no ...

Don't settle for sluggish Wi-Fi. Learn what internet speed tests mean and how to troubleshoot and fix common issues. Joe Supan is a senior writer for CNET covering home technology, broadband, and ...

The scientist who discovered the SRY gene test that the International Olympic Committee is now relying on to determine athletes' eligibility for women's events says it should not be used in such a ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

Over 1,200 driving tests have been cancelled in the past two weeks since new rules requiring proof of car insurance came into effect, the Road Safety Authority has revealed. The regulations were ...

Pentagon Under Fire as Troops Allegedly Told Iran War Will Spark 'Armageddon' and Jesus' Return Claims that US troops are failing drug tests on purpose by using marijuana in what some have called a ...

IOC introduces gene-screening test for female category eligibility New rules stop transgender athletes competing in female category events Exceptions for rare sex development disorders like CAIS ...

You’ve probably seen the clock it vs finger clap debate pop up everywhere—comments, reels, even group chats—and thought you had it figured out. Turns out, a lot of people online are confidently doing ...

Scientists are inching closer to solving one of imaging’s toughest problems: visualizing α-synuclein pathology in the living brain. At the International Conference on Alzheimer’s and Parkinson’s ...